Question

Quote






anonymous said:
As a rep who left, unfortunately, we all saw this coming. When we launched Fuse a couple of years ago, the system had issues but we were pressured to demo and over time, we burned a lot of bridges by doing demos with a clinically unacceptable system. No surprise there. I think we all believe in the 330 degree view but when you can't transfer quality images to an ERW, your printed images are poor, your scope breaks down during demos, or your Fuse customers are pissed when they need to constantly send in scopes for repair, those factors outweigh a 300 degree view.

And we saw the reps who were fired because they brought up these concerns and refused to demo until the system was fixed.

Back when Fuse was launched at our NSM, EC called out the entire sales force and told us that we better sell the sytem for $300K a room or else he would be furious. Is he selling it for $300K or is he going for the cheapest price point nowadays?
Click to expand...

Yes! New York Eddie. "If you can't sell this scope for $300K you need to just leave the room now." What a dumbass. Or was it $350K?

Or how about our management team directing our recruiters to position this job as the average rep making $300K. That was probably my favorite.

What a nightmare experience. Never been around a more collectively incompetent, unethical bunch. You're all finally getting yours and karma's a bitch.
 






anonymous said:
Yes! New York Eddie. "If you can't sell this scope for $300K you need to just leave the room now." What a dumbass. Or was it $350K?

Or how about our management team directing our recruiters to position this job as the average rep making $300K. That was probably my favorite.

What a nightmare experience. Never been around a more collectively incompetent, unethical bunch. You're all finally getting yours and karma's a bitch.
Click to expand...

That was it! If you can't sell this scope for $300K, you need to leave the room right now. That was after Tessa's dad talk to the sales force.
 






anonymous said:
It's extremely depressing. Finance guy above has a pretty good point. We've been losing a ton of money with no turnaround in sight. We have a couple more quarters to go in cash. Then what?

And to EC in New York. What a case in narcissism. I've never seen someone so self-important and so universally loathed. Come to think of it, you fit the brand bro. I see your anger, man. You'll end up taking a harder fall than even MG in a few months, so I totally get it.
Click to expand...
Well, there was about $103 million in cash after Q3 2015, so there is more than a couple quarters left. They recently told investors at a presentation that they expect to be profitable in 2018. If that is true, there is nothing to worry about, however, if the earnings stays the same as it has for the last 2 years for the next 2 without losses becoming less in 2017, the company will cease to exist by 2018. The stock price really doesn't matter right now, except for the fact that it reflects that much of the market doesn't believe that EC will be profitable by 2018. In order to stop losing money at a rate that puts EC out of business, one of two things is going to have to happen. Either FUSE sales have to pick up within a year, or they get rid of FUSE, cut costs & focus on Path, SUP & scope repair. Scope repair business has suffered due to those resources being allocated to FUSE. The customer satisfaction with repairs is at an all time low. It isn't the guys in Memphis's fault either, they have surely been told that FUSE service comes first. Basically, the whole survival of the company comes down to FUSE. With Olympus's new 3D technology in surgical scopes coming to their colonoscopes & gastroscopes in the near future, it doesn't look good. The one thing that has helped EC with regards to this is the ERCP scope disaster that Olympus has been dealing with. It has shifted Olympus's focus to replacing the elevators on those scopes & away from releasing the next series with 3D, and I assume allowed EC to benefit from a renewed focus on infection control with kits. What could have happened if EC wasn't dicking around with FUSE was they had a real opportunity to grow the scope repair business. Olympus lost a lot of credibility with the argument that they are the only company that can repair their scopes properly & prevent infection control issues. I am not trying to be ugly, but the device business isn't going to improve unless they sell a bunch of FUSE. The devices really aren't that good unless a lot of changes have occurred in the last couple years. You are basically competing for commodity products in devices because the autoband sucks, & there are no ERCP or specialty products except for Bonastent, which is the best device EC has. Also, can someone answer a question for me? Does EC have the Bonastent airway stents or the covered biliary stents approved in the US yet? Without strong specialty devices like ERCP products, stents, dilation balloons, a quality esophageal bander etc, you are basically going to be Conmed or US Endo at best. EC has good foreign body retrieval, but needs something comparable to a Rothnet as well. EC's problem is that they don't really have an identity from a product that clearly differentiates them in the device area.
 






anonymous said:
Well, there was about $103 million in cash after Q3 2015, so there is more than a couple quarters left. They recently told investors at a presentation that they expect to be profitable in 2018. If that is true, there is nothing to worry about, however, if the earnings stays the same as it has for the last 2 years for the next 2 without losses becoming less in 2017, the company will cease to exist by 2018. The stock price really doesn't matter right now, except for the fact that it reflects that much of the market doesn't believe that EC will be profitable by 2018. In order to stop losing money at a rate that puts EC out of business, one of two things is going to have to happen. Either FUSE sales have to pick up within a year, or they get rid of FUSE, cut costs & focus on Path, SUP & scope repair. Scope repair business has suffered due to those resources being allocated to FUSE. The customer satisfaction with repairs is at an all time low. It isn't the guys in Memphis's fault either, they have surely been told that FUSE service comes first. Basically, the whole survival of the company comes down to FUSE. With Olympus's new 3D technology in surgical scopes coming to their colonoscopes & gastroscopes in the near future, it doesn't look good. The one thing that has helped EC with regards to this is the ERCP scope disaster that Olympus has been dealing with. It has shifted Olympus's focus to replacing the elevators on those scopes & away from releasing the next series with 3D, and I assume allowed EC to benefit from a renewed focus on infection control with kits. What could have happened if EC wasn't dicking around with FUSE was they had a real opportunity to grow the scope repair business. Olympus lost a lot of credibility with the argument that they are the only company that can repair their scopes properly & prevent infection control issues. I am not trying to be ugly, but the device business isn't going to improve unless they sell a bunch of FUSE. The devices really aren't that good unless a lot of changes have occurred in the last couple years. You are basically competing for commodity products in devices because the autoband sucks, & there are no ERCP or specialty products except for Bonastent, which is the best device EC has. Also, can someone answer a question for me? Does EC have the Bonastent airway stents or the covered biliary stents approved in the US yet? Without strong specialty devices like ERCP products, stents, dilation balloons, a quality esophageal bander etc, you are basically going to be Conmed or US Endo at best. EC has good foreign body retrieval, but needs something comparable to a Rothnet as well. EC's problem is that they don't really have an identity from a product that clearly differentiates them in the device area.
Click to expand...

Here is a question that maybe you could answer for me. Why are you speaking on something you know nothing about or a company you don't work for? The repair facility isn't in Memphis...its Nashville. Semantics...maybe, but don't try to speak to something when yu don't know the facts. Everyone knows the stock sucks and no matter how many times I see the posts regarding the shit price...its going to take time to get better. It took almost 6+ years for the BSC price to rebound after the Guidant acquisition. Stock means nothing right now.

As far as Bonastent goes, why does it matter if the covered airway/biliary stent is available?
 






anonymous said:
Here is a question that maybe you could answer for me. Why are you speaking on something you know nothing about or a company you don't work for? The repair facility isn't in Memphis...its Nashville. Semantics...maybe, but don't try to speak to something when yu don't know the facts. Everyone knows the stock sucks and no matter how many times I see the posts regarding the shit price...its going to take time to get better. It took almost 6+ years for the BSC price to rebound after the Guidant acquisition. Stock means nothing right now.

As far as Bonastent goes, why does it matter if the covered airway/biliary stent is available?
Click to expand...

Hahaha!!!! OMG that's great!!!!!! You're comparing the BSC and EndoChoice stock like there's a correlation and it's just a matter of time before GI recovers.

You must work for EndoChoice with those brains and that logic.

And as far as this whole "stock price means nothing right now" commentary. That's what your management and leadership is telling you to calm you down. It means everything. EVERYTHING. It's your fucking valuation on which all future funding rounds and financing would be based on. Wow are you dumb.
 






anonymous said:
Here is a question that maybe you could answer for me. Why are you speaking on something you know nothing about or a company you don't work for? The repair facility isn't in Memphis...its Nashville. Semantics...maybe, but don't try to speak to something when yu don't know the facts. Everyone knows the stock sucks and no matter how many times I see the posts regarding the shit price...its going to take time to get better. It took almost 6+ years for the BSC price to rebound after the Guidant acquisition. Stock means nothing right now.

As far as Bonastent goes, why does it matter if the covered airway/biliary stent is available?
Click to expand...

The person may have been wrong on our location for our repair facility but he is dead on with the turn around time for Olympus repairs because our repair facility is absolutely over-worked by Fuse repairs. Turn around time is awful for Olympus scopes and that doesn't take into consideration the lack of loaner scopes for either our Fuse or Olympus customers.

I don't put the blame on the Nashville crew. I put the blame on Germany for a bad product.
 






anonymous said:
Here is a question that maybe you could answer for me. Why are you speaking on something you know nothing about or a company you don't work for? The repair facility isn't in Memphis...its Nashville. Semantics...maybe, but don't try to speak to something when yu don't know the facts. Everyone knows the stock sucks and no matter how many times I see the posts regarding the shit price...its going to take time to get better. It took almost 6+ years for the BSC price to rebound after the Guidant acquisition. Stock means nothing right now.

As far as Bonastent goes, why does it matter if the covered airway/biliary stent is available?
Click to expand...

Eddie, is that you again, telling us that the stock means nothing right now? Try telling that to the board. I get it though. Your friends in leadership are feeling the heat and no one would be surprised that some of those people could get canned soon by the board of directors. Once they get fired, all of the other "basement founders" will probably leave as well.
 






It's a shame to see Holloways baby (scope repair) get ran into the shitter by pushing fuse. I have customers who have been with Holloway before EC aquired them and have loved them up until the last year or two.

We're sinking all this money into fuse without building the infrastructure. I want to be here, I believe there is a possibility of succeeding in what we want to achieve but the direction and way it's handled needs to be changed.


anonymous said:
The person may have been wrong on our location for our repair facility but he is dead on with the turn around time for Olympus repairs because our repair facility is absolutely over-worked by Fuse repairs. Turn around time is awful for Olympus scopes and that doesn't take into consideration the lack of loaner scopes for either our Fuse or Olympus customers.

I don't put the blame on the Nashville crew. I put the blame on Germany for a bad product.
Click to expand...
 






anonymous said:
It's a shame to see Holloways baby (scope repair) get ran into the shitter by pushing fuse. I have customers who have been with Holloway before EC aquired them and have loved them up until the last year or two.

We're sinking all this money into fuse without building the infrastructure. I want to be here, I believe there is a possibility of succeeding in what we want to achieve but the direction and way it's handled needs to be changed.
Click to expand...
 












anonymous said:
It's extremely depressing. Finance guy above has a pretty good point. We've been losing a ton of money with no turnaround in sight. We have a couple more quarters to go in cash. Then what?

And to EC in New York. What a case in narcissism. I've never seen someone so self-important and so universally loathed. Come to think of it, you fit the brand bro. I see your anger, man. You'll end up taking a harder fall than even MG in a few months, so I totally get it.
Click to expand...

Hey Cali rep, you're so nar nar bro!
 






clearly Endochoice is in disarray and wont be around long. The EC in NY has to be envious of his older brothers success at PENTAX. Even PENTAX doesn't struggle this bad at trying to compete. EC should have never left PENTAX and should have swallowed his pride working for his older and wiser brother....
 






anonymous said:
clearly Endochoice is in disarray and wont be around long. The EC in NY has to be envious of his older brothers success at PENTAX. Even PENTAX doesn't struggle this bad at trying to compete. EC should have never left PENTAX and should have swallowed his pride working for his older and wiser brother....
Click to expand...

Why the fascination with EC?
 






anonymous said:
clearly Endochoice is in disarray and wont be around long. The EC in NY has to be envious of his older brothers success at PENTAX. Even PENTAX doesn't struggle this bad at trying to compete. EC should have never left PENTAX and should have swallowed his pride working for his older and wiser brother....
Click to expand...

Um, you do realize Pentax is financially in a worse situation in the US and are very likely pulling out of the US market.

Yes, fuse is a financial suck for Endochoice, but to think the entirety of the company is going to simply close shop and go away is naive.
 












anonymous said:
Probably because he calls out other reps in the company but we know that he gets favors from our president or VP to close deals.
Click to expand...

Is that what you tell yourself to make you feel better? I am not getting the same "favors" as other people. Come on, man!

I trained with EC & he is a pro. He has been in GI for 20 years. He knows his market, his docs trust him, he works hard and he knows what it takes to close a deal.
 






This thread is entertaining. Keep it up. However, for anyone who is thinking of joining EndoChoice, for the most part, the posts here are spot on about product failures, issues with Fuse, management, etc. I recently left and a lot of the frustrations being vented here are dead on.

And before the cheerleaders jump on and tell me, "Good riddance", I sold Fuse and can speak personally about how big of a CF the Fuse implementation has been at EndoChoice. Good luck.
 






anonymous said:
This thread is entertaining. Keep it up. However, for anyone who is thinking of joining EndoChoice, for the most part, the posts here are spot on about product failures, issues with Fuse, management, etc. I recently left and a lot of the frustrations being vented here are dead on.

And before the cheerleaders jump on and tell me, "Good riddance", I sold Fuse and can speak personally about how big of a CF the Fuse implementation has been at EndoChoice. Good luck.
Click to expand...

Thanks for your input, Phil. Seriously, why the hell do people express there opinions about a company they no longer work for. You left...congrats and good luck at Veran. Quit talking shit about every little thing. It's annoying. We get it...you hate EndoChoice.
 






There has been so much turnover at this company over the last 6-12 months that for you to try to pin these postings on one person is funny.

People who no longer work here can't have opinions about EndoChoice? Wow. Talk about burying your head in the sand. Those people tend to have valid opinions about the issues that are going on with a company. You may not want to hear them but it doesn't mean that they aren't honest.
 






Top Bottom
Back
Quote